Academic literature on the topic 'Neuropathic pain, chronic pain, verbal pain description'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Neuropathic pain, chronic pain, verbal pain description.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Neuropathic pain, chronic pain, verbal pain description":
1
Castro-Costa, Carlos Maurício de, Abelardo de Queiroz Campos Araújo, Carlos C. Câmara, Ayrton S. Ferreira, Terezinha de Jesus T. Santos, Samuel Bovy de Castro-Costa, Raimundo Neudson M. Alcântara, and Graham P. Taylor. "Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients." Arquivos de Neuro-Psiquiatria 67, no. 3b (September 2009): 866–70. http://dx.doi.org/10.1590/s0004-282x2009000500016.
Abstract:
OBJECTIVE: Tropical Spastic Paraparesis/HTLV-I Associated Myelopathy (TSP/HAM) is a chronic myelopathy, and pain has been mentioned as a frequent sensory symptom in this condition. The authors aimed at analyzing this symptom in a TSP/HAM patients series. METHOD: For this, 46 patients were analyzed considering demographic and clinical characteristics and complaint of pain as to verbal description, time of onset and classification, correlated with the degree of motor disability and type of pain. RESULTS: Among the 46 TSP/HAM patients, 28 (60.8%) complained of pain, predominant in the early phase of the disease. Most of the patients exhibited neuropathic characteristics of pain, correlated with increased motor disability. CONCLUSION: Pain in TSP/HAM patients is a frequent and early symptom, and the neuropathic type is predominant (57.1%) and paralleled with increased incapacitation. The pathogenic involvement of cytokines may possibly be involved in the meaning of this symptom in this condition.
2
Kotelnikova, A. V., I. V. Pogonchenkova, V. D. Daminov, A. A. Kukshina, and N. I. Lazareva. "Virtual reality in the correction of pain syndrome in patients with degenerative-dystrophic joints and spine diseases." Bulletin of Restorative Medicine 96, no. 2 (April 24, 2020): 41–48. http://dx.doi.org/10.38025/2078-1962-2020-96-2-41-48.
Abstract:
Musculoskeletal system diseases require active motor rehabilitation, as a rule, but presence of severe pain syndrome might become a barrier, leading to the development of kinesiophobia and reducing motivation for treatment in patients. In recent decades, non-invasive methods of pain control, in particular virtual reality (VR) and augmented reality (AR) have been commonly used on a par with drug therapy. The purpose of this study is to provide a scientific base for the effectiveness of including a high-tech VR device (Vive Focus Plus EEA Virtual Reality Helmet), in to psychological rehabilitation of a pain syndrome in patients with chronic degenerative-dystrophic diseases of major joints and spine. The study involved 84 patients (24 men and 60 women aged 56±14.4) of a rehabilitation hospital with a severe pain syndrome and motor disorders corresponding to ICF Class 1 or 2. To analyse the characteristics of the subjective pain perception, the method of multidimensional semantic description based on the adapted Russian version of the McGill Pain Questionnaire was applied, and the Tampa Scale was used to kinesiophobia assessment. The VR technology was implemented via usage of the Vive Focus Plus EEA Virtual Reality Helmet tool (10 procedures). The effectiveness of using VR technology was evaluated through monitoring of pain dynamics and the kinesiophobia level prior to the study onset and at the end of hospitalization. As a result, the study has shown that there was no nosological specificity in the description of pain, or the differences in its verbal characteristics representing nociceptive and neuropathic components. Technology of ‘virtual immersion in 3D reality’ makes it possible to influence effectively on pathophysiological mechanisms links in the development of chronic psychologically determined, neuropathic and mixed-origin pain.
3
Niscola, Pasquale, Claudio Cartoni, Claudio Romani, Marco Giovannini, Gregorio Brunetti, Gianna Maria D’Elia, Luca Cupelli, Paolo De Fabritiis, Robin Foà, and Franco Mandelli. "Epidemiology and Characteristics of Pain in Patients Suffering from Advanced Haematological Malignancies in the Home Care (HC) Setting: An Italian Survey." Blood 108, no. 11 (November 16, 2006): 5502. http://dx.doi.org/10.1182/blood.v108.11.5502.5502.
Abstract:
Abstract Background. The epidemiology of pain in patients with advanced haematological malignancies followed at home, 469 consecutive patients has been followed over a six years. Methods. Each pain syndrome (PS) was properly assessed and treated according to the WHO ladder. The pain intensity was reported by a Numerical Analogue Scale, which rated score ranging from 0 (no pain) to 10 (the most severe), or, in less complaint patients, by a verbal description. Each PS was classified as deep somatic, superficial somatic, neuropathic and mixed or unknown. Results. Of 469 patients, 258 (55%) were males; the median age was 67 (4–95) years. Out of 469 patients, 244 (52%) experienced almost one PS, for a total of 284, which intensity was rated from mild to moderate in 92 (31%) and from moderate to severe in 192 (69%) of them respectively. The 244 patients who experienced pain were significantly younger than those without pain (57 ± 21 versus 69±16, P< 0.0005). Moreover, the group of less than 20 old years patients presented a higher incidence of pain compared to others (85% versus 49%, P=0.0007). The patients affected by Multiple Myeloma (MM), Acute Lymphoblastic Leukaemia (ALL), non Hodgkin’s Lymphomas (NHL) and Blastic Crisis showed a higher incidence of pain compared to other disease groups (P=0.0011). Among acute leukemias, ALL patients presented a higher incidence of pain compared to those affected by myeloblastic forms (79% versus 41%, P= 0.0002). An effective pain control was achieved within 24 hours in 259/284 (92%) without any admission. PS was diagnosed as deep somatic, superficial somatic, visceral, neuropathic and mixed (somatic + neuropathic) in the 56 %, 15 %, 14 %, 7 % and 8 % of the PS respectively. A higher incidence of deep somatic pain was recorded in all diagnosis groups. Moreover, out of the 39 visceral PS, 33 (85%) have been recorded among patients with NHL and 6 (15%) in the others (P=0.0001). MM patients presented a higher rate of the incident pain (P<0.001). The causative mechanisms of PS were directly referable to underlying diseases, to their clinical complications and to concomitant and unrelated conditions in the 69%, 22% and 9% of cases respectively. The most involved sites were: the spine (27%), the abdomen (20%), the legs (15%), the thorax (11%) and orofaringeal tract (10%). Conclusion. our data show that pain is a relevant problem in advanced onco-haematological patients, which mostly present disease-related PS, reflecting specific pathological activity of the underlying malignancy. Table 1. Incidence of pain and distribution of pain syndromes among the haematological malignancies Malignancy PP/TP (No) Incidence of pain (%) Pain Syndromes (No) PP: Pain Patients; TP: Total Patients, No: number, MM: Multiple Myeloma, ALL: Acute Lymphoblastyc Leukemia, NHL; Non Hodgkin’s Lymphomas; BC: Blastic Crisis, HD: Hodgkin’s Disease, CLL: Chronic Lymphocytic Leukemia, Acute Myeloblastyc Leukemia, MDS: Myelodysplastyc Syndromes, CMPD: Chronic Myeloproliferative Disorders. MM 35/39 90 38 ALL 31/39 79 40 NHL 77/128 60 89 BC 29/56 52 34 HD 5/11 45 5 CLL 10/24 42 11 AML 28/69 41 34 MDS 20/63 32 22 CMPD 5/33 18 8 Others 3/7 43 3 Total 243/469 52 284
4
Boureau, F., J. F. Dubrère, and M. Luu. "Study of verbal description in neuropathic pain." Pain 41 (January 1990): S465. http://dx.doi.org/10.1016/0304-3959(90)93045-y.
5
Boureau, F., J. F. Doubrère, and M. Luu. "Study of verbal description in neuropathic pain." Pain 42, no. 2 (August 1990): 145–52. http://dx.doi.org/10.1016/0304-3959(90)91158-f.
6
Koriachkin, Viktor A., Arina P. Spasova, Vladimir V. Khinovker, Yaakov I. Levin, and Dmitry O. Ivanov. "Current terminology of chronic pain." Regional Anesthesia and Acute Pain Management 15, no. 1 (July 15, 2021): 9–17. http://dx.doi.org/10.17816/1993-6508-2021-15-1-9-17.
Abstract:
BACKGROUND: Chronic pain is a common problem that exerts a significant impact on individuals and society as a whole. Pain syndrome is one of the most common explanations for patients need for medical care, and it causes major suffering in humans. Thus far, chronic pain lacks a generally accepted terminology and classification.
The review aimed to present the current terminology and classification of chronic pain.
MATERIALS AND METHODS: Two independent researchers searched for publications for the period of January 2010 to October 2020 in the databases PubMed, MEDLINE, EMBASE, The Cochrane Library, Google Scholar, and the International Association for the Study of Pain. The last search query was performed on October 25, 2020. The search identified 423 studies, and 397 of them were excluded because they described the pathophysiology and treatment of chronic pain syndromes. The remaining 26 publications formed the basis of this review.
RESULTS: The review presents the current terminology and classification of chronic pain, which is defined as pain that lasts for 3 months or more after the underlying pathology is cured. The work presents the description of terms such as chronic primary pain, chronic secondary pain, cancer-associated chronic pain, chronic postoperative or post-traumatic pain, chronic neuropathic pain, chronic secondary cephalgia or orofacial pain, chronic secondary visceral pain, and chronic secondary musculoskeletal pain. Additional characteristics of chronic pain, including the intensity of pain, the severity of suffering, and physical dysfunction, are also given.
CONCLUSION: The presented modern terminology and classification of chronic pain will contribute not only to the correct formulation of diagnosis established in a patient with chronic pain but also to the implementation of multimodal analgesia, epidemiological studies and, ultimately, the choice of proper strategy for addressing chronic pain by healthcare organizers. The result is also expected to lead to adequate funding for resolving this intricate problem.
7
Garnier, Fanny, Cyrus Motamed, Philippe Sitbon, and Jean Louis Bourgain. "Postoperative Pain Profile After Major Cervicofacial Cancer Surgery." European Journal of Clinical Medicine 2, no. 2 (March 8, 2021): 1–6. http://dx.doi.org/10.24018/clinicmed.2021.2.2.20.
Abstract:
Background: Despite its anticipation, postoperative pain may be still poorly managed in some cases, such as in patients undergoing major cervicofacial cancer surgery. Indeed, the postoperative pain associated with these surgeries is complex and multifactorial. Objective: To assess the profile of postoperative pain scores and opioid requirements in a cohort of consecutive patients undergoing major cancer cervicofacial surgery with or without reconstruction. Methods: A cohort of 42 consecutive patients was studied. The following parameters were recorded: patients characteristics, type of surgery, preoperative medication preoperative pain scores, and postoperative pain score (5-point numerical verbal scale) upon arrival at the postanesthesia care unit (PACU) and at Day 1 to Day 7 (11-point visual numeric scale), the presence or absence of neuropathic and/or chronic pain one year later (determined by a phone interview), and morphine consumption. Results: All patients had a pain score of less than 3 in the PACU. From postoperative day 1 to day 7, pain scores were extremely variable and stayed high or even increased up to 7 in many patients. At the one-year phone interview, some patients had neuropathic and chronic pain.Discussion: Postoperative pain profiles in major cervicofacial cancer are complex, with high interindividual variability and with cases with neuropathic patterns and high pain scores that can last up to 7 days postoperatively.
8
Faillace, César, and Jozélio Freire de Carvalho. "Still's Disease and Recurrent Complex Regional Pain Syndrome Type-I: The First Description." Autoimmune Diseases 2012 (2012): 1–3. http://dx.doi.org/10.1155/2012/842564.
Abstract:
Complex regional pain syndrome (CRPS) is a chronic neuropathic pain disorder characterized by neuropathic pain associated with local edema and changes suggestive of autonomic involvement such as altered sweating, skin color, and skin temperature of the affected region. CRPS was described associated with several diseases, such as trauma, psychiatric conditions, and cancer. However, no case associated with Still's disease has been previously described. In this paper, the authors describe the first case of CRPS associated with Still's disease.
9
Skorupska, Elżbieta, Magdalena Atarowska, and Włodzimierz Samborski. "Sympathetic Nervous System activity – a new concept of the complicated etiology of low back pain radiates distally at the extremities." Journal of Medical Science 83, no. 1 (March 30, 2014): 53–56. http://dx.doi.org/10.20883/medical.e44.
Abstract:
Varied and complicated etiology of low back pain radiates distally at the extremities is still causing disagreement and controversies around the issue of its diagnosis and treatment. New research data demonstrated that almost one in five persons with back pain experience symptoms indicative of neuropathic pain component. The neuropathic involvement is not completely understood, and different mechanisms are thought to play important role. A combination of nociceptive and neuropathic pain-generating mechanism is thought to be involved, which established the term mixed pain syndrome. In the pathomechanism of neuropathic pain the lesion, trauma or overloading of the disc is thought to be a primary source of the neuropathic pain but the concept of neuropathic component of pain is more probable for chronic stage than acute. Assessment of neuropathic pain involves a systematic approach which includes a series steps; past and present history, detailed description of pain distribution, quality, pain intensity and neurological examination with emphasis on sensory testing. The sensory examinations need often to be supply neurophysiological testing and quantitate sensory testing. Some groups of the drugs are thought to be useful e.g. tricyclic antidepressant, sodium channel blockers (e.g. carbamazepine), gabapentin, opioids, NMDA (N-methyl-D-aspartate) receptor blockers and others for neuropathic pain treatment. The use of specific kind of the drugs depends on the symptoms and examinations findings.
10
Spasova, Arina P., O. Y. Barysheva, G. P. Tikhova, V. V. Maltsev, and V. A. Koriachkin. "Factors and characteristics of chronic pain in survivors of critical conditions." Regional Anesthesia and Acute Pain Management 14, no. 4 (December 8, 2020): 193–205. http://dx.doi.org/10.17816/1993-6508-2020-14-4-193-205.
Abstract:
This study aimed to determine the factors that affect the development of chronic pain in patients who recovered from a critical illness and to explore characteristics of pain.
Material and methods. This study included a total of 112 patients with surgical pathology who stayed in the intensive care unit (ICU) and subsequently discharged from the hospital. Before discharge, patients were assessed using a short pain questionnaire, the PainDetect questionnaire to assess the neuropathic component of pain, and the HADS questionnaire to verify the presence of anxiety and depression. After 6 and 12 months, catanamnestic data were analyzed, and neuro-orthopedic examination and repeat testing were performed. The duration of ventilation and ICU and hospital stays were assessed as risk factors. The APACHE-II scale score and the maximum SOFA scale score were used as severity parameters of critical conditions. The maximum level of C-reactive protein (CRP) was recorded as a marker of inflammation. The Charlson comorbidity index was used to assess baseline comorbidity.
Results. After 6 months, pain syndrome developed in 55.6% of the patients, and after 12 months, the average pain intensity was 4 points on the verbal rating scale in 59% of the patients. Neuropathic pain was diagnosed in 34% of the patients. The most frequent location of pain was the shoulder joint area, and both shoulders were affected by pain in 58.2% of the patients. In the period from 6 months to 1 year after discharge from the ICU, the risk factors for chronic pain were the duration of ventilator use, ICU stay, and CRP level. Age and gender did not affect the development of chronic pain in patients who recovered from critical illness.
Conclusions. Chronic pain is a complication in more than half of the patients with critical illness. A third of patients with chronic pain experienced neuropathic pain, which requires a comprehensive approach to relieve pain.
Dissertations / Theses on the topic "Neuropathic pain, chronic pain, verbal pain description":
1
Bennett, Michael I., Nadine Attal, Miroslav M. Backonja, Ralf Baron, Didier Bouhassira, Rainer Freynhagen, Joachim Scholz, Thomas R. Tölle, Hans-Ulrich Wittchen, and Troels Staehelin Jensen. "Using screening tools to identify neuropathic pain." Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2013. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-112626.
Abstract:
It is widely accepted that the unique painful and non-painful sensations in neuropathic pain are the result of particular mechanisms, and that specific management strategies for neuropathic pain should be applied to tackle them. Ideally, the treatment of chronic pain should be directed at eliminating the cause of pain, but in reality this is rarely possible. The management of chronic pain is therefore often limited to reducing the intensity of such pain and associated symptoms.
Pain is essentially a subjective phenomenon described with patient-specific symptoms and expressed with a certain intensity. It therefore makes sense to examine the value of verbal descriptors and pain qualities as a basis for distinguishing neuropathic pain from other types of chronic pain. Work by Dubuisson and Melzack (1976) and later by Boureau et al. (1990) supported anecdotal opinion that key words might be discriminatory for neuropathic pain. In the last 5 years, much research has been undertaken to develop screening tools for this purpose. These tools are based on verbal pain description with, or without, limited bedside testing. This paper reviews the strengths and weaknesses of such tools.
2
Bennett, Michael I., Nadine Attal, Miroslav M. Backonja, Ralf Baron, Didier Bouhassira, Rainer Freynhagen, Joachim Scholz, Thomas R. Tölle, Hans-Ulrich Wittchen, and Troels Staehelin Jensen. "Using screening tools to identify neuropathic pain." Technische Universität Dresden, 2007. https://tud.qucosa.de/id/qucosa%3A26855.
Abstract:
It is widely accepted that the unique painful and non-painful sensations in neuropathic pain are the result of particular mechanisms, and that specific management strategies for neuropathic pain should be applied to tackle them. Ideally, the treatment of chronic pain should be directed at eliminating the cause of pain, but in reality this is rarely possible. The management of chronic pain is therefore often limited to reducing the intensity of such pain and associated symptoms.
Pain is essentially a subjective phenomenon described with patient-specific symptoms and expressed with a certain intensity. It therefore makes sense to examine the value of verbal descriptors and pain qualities as a basis for distinguishing neuropathic pain from other types of chronic pain. Work by Dubuisson and Melzack (1976) and later by Boureau et al. (1990) supported anecdotal opinion that key words might be discriminatory for neuropathic pain. In the last 5 years, much research has been undertaken to develop screening tools for this purpose. These tools are based on verbal pain description with, or without, limited bedside testing. This paper reviews the strengths and weaknesses of such tools.
Book chapters on the topic "Neuropathic pain, chronic pain, verbal pain description":
1
Bennett, Michael I. "Screening tools and measurement tools for neuropathic pain." In Neuropathic Pain, 37–43. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199563678.003.0005.
Abstract:
Verbal description differs between neuropathic and nociceptive pain and can contribute important information to the assessment process Screening tools alert the clinician to the possible presence of neuropathic pain mechanisms but they do not replace clinical diagnosis Measurement tools assess the intensity of particular qualities of neuropathic pain once a diagnosis has been made...
2
Freynhagen, Rainer. "Neuropathic back pain." In Neuropathic Pain, 85–92. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199563678.003.0010.
Abstract:
Approximately 25–30% of patients with chronic low back pain have a neuropathic component, most usually chronic lumbar radicular pain. Distinguishing between radicular and pseudoradicular syndromes in low back pain may have some clinical relevance but in practice is difficult to achieve. A neuropathic component in low back pain can be identified through a combination of verbal descriptors and thorough clinical examination including evoking nerve root tension signs or dural irritation (e.g. straight leg raise). There is poor correlation between radiologic imaging and clinical symptoms....
3
O’Brien, Juliana H., and Maggie C. Root. "Pediatric Pain." In Oxford Textbook of Palliative Nursing, edited by Betty Rolling Ferrell and Judith A. Paice, 773–82. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780190862374.003.0064.
Abstract:
Children and infants experience pain as a serious complication of disease and injury, but only recently have clinicians come to understand how children experience pain. Exposure to painful injury is associated with psychological consequences in infants and children, including posttraumatic stress symptoms, neurodevelopmental issues, increased anxiety, and cortical dysfunction in childhood. In seriously ill infants, pain may be associated with increased morbidity and mortality; in older children, untreated pain can lead to decreased functioning, social isolation, sleep disorders, and mood changes. Prevention and relief of pain for this vulnerable population is essential. Pain assessment and management in infants and children require that palliative care nurses understand the developmental stages of childhood. This chapter provides a recommended approach to pain assessment and pain management in children. It outlines age-specific and developmentally appropriate pain assessment tools. It describes commonly observed pain behaviors in verbal and nonverbal children. It highlights the management differences between acute pain, neuropathic pain, and chronic pain. It details a combined nonpharmacologic and pharmacologic (including weight-based dosing) approach for pain management.
4
Curtin, John. "Pain management." In Oxford Handbook of Cancer Nursing, edited by Mike Tadman, Dave Roberts, and Mark Foulkes, 549–68. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198701101.003.0046.
Abstract:
Pain is described as being whatever the experiencing person says it is, and their perception of pain is determined by their mood and morale and the meaning of the pain for them. Cancer pain is common, and prevalence is related to the stage of the illness: 59% in patients undergoing treatment, and 64% in those with advanced disease. Pain is multi-causal and multidimensional, and a holistic, interdisciplinary approach to assessment is necessary, encompassing physical, psychological, social, and spiritual aspects of pain (together are ‘total pain’). A narrative approach to pain assessment is helpful, keeping the focus on the patient and their experience. Pain assessment tools can also be used to identify where pain is and how much it hurts. These include: pain body map, visual analogue scales (VAS), verbal rating scales (VRS), numerical rating scales (NRS), and Brief Pain Inventory (BPI). Classifications of pain include acute and chronic pain, nociceptive pain caused by the stimulation of nerve endings, and neuropathic pain caused by nerve dysfunction or compression. Analgesic drugs may be given according to the World Health Organization's pain relief ladder: step 1, non-opioid analgesics such as paracetamol and non-steroidal anti-inflammatory drugs; step 2, mild opioids like codeine with or without non-opioid analgesics; and step 3, strong opioids like morphine with or without non-opioid analgesics. Non-pharmacological interventions for pain management include transcutaneous electrical nerve stimulation (TENS), massage, distraction, relaxation, breathing exercises, comfort measures, and presence of the nurse. Effective communication at all stages of management is essential.